Else Nutrition Shares Rally With Plans for Danone Collaboration
By Robb M. Stewart
Else Nutrition's shares soared Monday after the company unveiled plans for a collaboration with Danone that will initially see its plant-based, soy-free products added to the dairy giant's portfolio.
In morning trading, the shares were 35% higher at C$0.44, narrowing their decline so far this year to 20%.
Else, which has been pushing to get its products on store shelves in North America and elsewhere, said that following due diligence by Danone the companies signed a letter of intent for a staged collaboration. They expect to sign a definitive deal by the end of March.
Initially, Else's products will be manufactured, marketed and commercialized by the European company. The companies plan to negotiate opportunities beyond product commercialization.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
November 13, 2023 10:49 ET (15:49 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
After Earnings, Is Baidu Stock a Buy, a Sell, or Fairly Valued?
-
Why Stocks Are Hitting Record Highs—and What Could Send Them Back to Earth
-
5 Stocks to Buy While They’re Trading at Big Discounts
-
Markets Brief: Tech Stocks Lead Ahead of Nvidia Earnings
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Lowe’s Earnings: Tumultuous Macro Weighs on Near-Term Results but Fails to Sway Our Long-Term View
-
Macy’s Earnings: Plan Taking Shape Despite Tough Environment
-
JPMorgan Investor Day: CEO Dimon Pushes Against More Stock Buybacks at Current Prices
-
Should You Buy and Hold an Artificial Intelligence Portfolio?
-
3 Cheap and Dependable Dividend-Growth Stocks to Buy
-
The Best Bank Stocks to Buy
-
After Earnings, Is Roblox Stock a Buy, Sell, or Fairly Valued?
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?